Form 4: Teladoc Director Converts RSUs to Common Stock
Insider Transaction Report
Teladoc Health Director Jason Eric Evans converted 1,016 restricted stock units into common stock on September 19, 2025, increasing his direct ownership of common shares.
Summary
- Jason Eric Evans, a Director of Teladoc Health, Inc. (TDOC), converted 1,016 restricted stock units (RSUs) into common stock.
- This transaction occurred on September 19, 2025.
- Following the conversion, Mr. Evans directly owns 8,129 shares of Teladoc Health common stock.
- He also retains 4,066 restricted stock units.
- The restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- The original grant of 12,195 restricted stock units was made on September 20, 2023, with vesting scheduled as one-third on the first anniversary of the grant date, and the remainder in eight substantially equal quarterly installments thereafter.
Sentiment
Score: 5
Explanation: The filing reports a routine insider transaction involving the conversion of restricted stock units into common stock, which is a scheduled event and does not inherently indicate a positive or negative sentiment regarding the company's immediate prospects.
Positives
- Director Jason Eric Evans increased his direct beneficial ownership of Teladoc Health common stock by 1,016 shares.
- The conversion of restricted stock units into common stock indicates a vesting event, aligning insider interests with shareholder value.
Future Outlook
NA
Industry Context
Insider equity conversions, such as the vesting and conversion of restricted stock units, are standard compensation practices across various industries, including healthcare technology. These transactions reflect the predetermined vesting schedules for executive and director compensation, rather than discretionary market-timing decisions.
Comparison to Industry Standards
- The conversion of restricted stock units (RSUs) into common stock is a standard practice for executive and director compensation across publicly traded companies, including those in the healthcare technology sector. This aligns with typical equity incentive plans designed to retain talent and align insider interests with long-term shareholder value.
Stakeholder Impact
- Shareholders: Increased direct ownership by a director may be viewed positively as it aligns management interests with shareholder value.
- Employees: The vesting of RSUs is a common component of executive compensation, reflecting standard practices for retaining key personnel.
Next Steps
- Future vesting events for the remaining 4,066 restricted stock units held by Jason Eric Evans, according to the original grant schedule.
Key Dates
| Date | Description |
|---|---|
| 09/20/2023 | Grant date of 12,195 restricted stock units to Jason Eric Evans. |
| 09/19/2025 | Conversion of 1,016 restricted stock units into common stock by Jason Eric Evans. |
| 09/22/2025 | Date of filing of the Form 4. |
Recommendation
holdThe filing details a routine conversion of restricted stock units into common stock by a director, which is a scheduled event and part of standard compensation. This transaction does not provide new fundamental information to alter an existing investment thesis, thus a 'hold' recommendation is appropriate.
Keywords
Teladoc Health, TDOC, Insider Transaction, Form 4, Jason Eric Evans, Restricted Stock Units, Common Stock, Director, Equity Conversion
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.